首页> 美国卫生研究院文献>Scientific Reports >Comparative proteomics reveals human pluripotent stem cell-derived limbal epithelial stem cells are similar to native ocular surface epithelial cells
【2h】

Comparative proteomics reveals human pluripotent stem cell-derived limbal epithelial stem cells are similar to native ocular surface epithelial cells

机译:比较蛋白质组学揭示人类多能干细胞衍生的角膜缘上皮干细胞与天然眼表上皮细胞相似

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Limbal epithelial stem cells (LESCs) are tissue-specific stem cells responsible for renewing the corneal epithelium. Acute trauma or chronic disease affecting LESCs may disrupt corneal epithelial renewal, causing vision threatening and painful ocular surface disorders, collectively referred to as LESC deficiency (LESCD). These disorders cannot be treated with traditional corneal transplantation and therefore alternative cell sources for successful cell-based therapy are needed. LESCs derived from human pluripotent stem cells (hPSCs) are a prospective source for ocular surface reconstruction, yet critical evaluation of these cells is crucial before considering clinical applications. In order to quantitatively evaluate hPSC-derived LESCs, we compared protein expression in native human corneal cells to that in hPSC-derived LESCs using isobaric tag for relative and absolute quantitation (iTRAQ) technology. We identified 860 unique proteins present in all samples, including proteins involved in cell cycling, proliferation, differentiation and apoptosis, various LESC niche components, and limbal and corneal epithelial markers. Protein expression profiles were nearly identical in LESCs derived from two different hPSC lines, indicating that the differentiation protocol is reproducible, yielding homogeneous cell populations. Their protein expression profile suggests that hPSC-derived LESCs are similar to the human ocular surface epithelial cells, and possess LESC-like characteristics.
机译:角膜上皮干细胞(LESC)是组织特异性干细胞,负责更新角膜上皮。影响LESC的急性创伤或慢性疾病可能会破坏角膜上皮更新,导致视力受到威胁和痛苦的眼表疾病,统称为LESC缺乏症(LESCD)。这些疾病不能用传统的角膜移植治疗,因此需要成功的基于细胞的治疗的替代细胞来源。源自人多能干细胞(hPSC)的LESC是眼表重建的潜在来源,但是在考虑临床应用之前,对这些细胞进行严格的评估至关重要。为了定量评估hPSC衍生的LESC,我们使用等压和绝对定量(iTRAQ)技术比较了天然人角膜细胞与hPSC衍生的LESC中的蛋白质表达。我们鉴定了所有样品中存在的860种独特蛋白质,包括涉及细胞周期,增殖,分化和凋亡,各种LESC小生境成分以及角膜缘和角膜上皮标记物的蛋白质。在源自两种不同hPSC系的LESC中,蛋白质表达谱几乎相同,这表明分化方案是可重现的,从而产生均质的细胞群。它们的蛋白表达谱表明,hPSC衍生的LESC与人眼表面上皮细胞相似,并具有LESC样特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号